NM_201596.3:c.1511C>T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_201596.3(CACNB2):​c.1511C>T​(p.Thr504Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00277 in 1,614,042 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T504T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0017 ( 2 hom., cov: 31)
Exomes 𝑓: 0.0029 ( 11 hom. )

Consequence

CACNB2
NM_201596.3 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:12O:1

Conservation

PhyloP100: 0.904

Publications

16 publications found
Variant links:
Genes affected
CACNB2 (HGNC:1402): (calcium voltage-gated channel auxiliary subunit beta 2) This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
CACNB2 Gene-Disease associations (from GenCC):
  • Brugada syndrome 4
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • cardiogenetic disease
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008203387).
BP6
Variant 10-18539252-C-T is Benign according to our data. Variant chr10-18539252-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 161212.
BS2
High AC in GnomAd4 at 253 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_201596.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
NM_201596.3
MANE Select
c.1511C>Tp.Thr504Ile
missense
Exon 14 of 14NP_963890.2Q08289-1
CACNB2
NM_201590.3
MANE Plus Clinical
c.1349C>Tp.Thr450Ile
missense
Exon 13 of 13NP_963884.2Q08289-3
CACNB2
NM_201597.3
c.1439C>Tp.Thr480Ile
missense
Exon 14 of 14NP_963891.1Q08289-8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
ENST00000324631.13
TSL:1 MANE Select
c.1511C>Tp.Thr504Ile
missense
Exon 14 of 14ENSP00000320025.8Q08289-1
CACNB2
ENST00000377329.10
TSL:1 MANE Plus Clinical
c.1349C>Tp.Thr450Ile
missense
Exon 13 of 13ENSP00000366546.4Q08289-3
CACNB2
ENST00000352115.10
TSL:1
c.1439C>Tp.Thr480Ile
missense
Exon 14 of 14ENSP00000344474.6Q08289-8

Frequencies

GnomAD3 genomes
AF:
0.00166
AC:
253
AN:
152078
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000773
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000787
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00300
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00148
AC:
373
AN:
251302
AF XY:
0.00153
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.000694
Gnomad ASJ exome
AF:
0.000298
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00282
Gnomad OTH exome
AF:
0.00228
GnomAD4 exome
AF:
0.00288
AC:
4214
AN:
1461846
Hom.:
11
Cov.:
31
AF XY:
0.00278
AC XY:
2022
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.000448
AC:
15
AN:
33478
American (AMR)
AF:
0.000961
AC:
43
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000421
AC:
11
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86252
European-Finnish (FIN)
AF:
0.0000374
AC:
2
AN:
53418
Middle Eastern (MID)
AF:
0.00260
AC:
15
AN:
5766
European-Non Finnish (NFE)
AF:
0.00358
AC:
3981
AN:
1111990
Other (OTH)
AF:
0.00235
AC:
142
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
239
478
716
955
1194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00166
AC:
253
AN:
152196
Hom.:
2
Cov.:
31
AF XY:
0.00142
AC XY:
106
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.000770
AC:
32
AN:
41534
American (AMR)
AF:
0.000786
AC:
12
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00300
AC:
204
AN:
68020
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00264
Hom.:
2
Bravo
AF:
0.00168
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00209
AC:
18
ExAC
AF:
0.00157
AC:
191
EpiCase
AF:
0.00316
EpiControl
AF:
0.00249

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
3
not specified (4)
-
-
3
not provided (4)
-
-
2
Brugada syndrome 4 (2)
-
1
-
Brugada syndrome (1)
-
-
1
CACNB2-related disorder (1)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Long QT syndrome (1)
-
-
1
Ventricular tachycardia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
16
DANN
Uncertain
1.0
DEOGEN2
Benign
0.094
T
Eigen
Benign
-0.22
Eigen_PC
Benign
-0.060
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.95
D
M_CAP
Benign
0.037
D
MetaRNN
Benign
0.0082
T
MetaSVM
Benign
-0.71
T
MutationAssessor
Benign
0.90
L
PhyloP100
0.90
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.67
N
REVEL
Benign
0.13
Sift
Benign
0.19
T
Sift4G
Benign
0.21
T
Polyphen
0.45
P
Vest4
0.050
MVP
0.88
MPC
0.22
ClinPred
0.011
T
GERP RS
3.6
Varity_R
0.086
gMVP
0.20
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143326262; hg19: chr10-18828181; API